MOESM3 of Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

Additional file 3: Figure S1. BCVA and CSFT outcomes at Month 12 stratified by presence of extrafoveal CNV lesions at baseline (FAS).